ENTITY

CSL (CSL AT)

1
Analysis
Health CareUnited States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
bearishCharter Hall
14 Aug 2023 05:12

MVIS Australia Equal Weight Index Rebalance Preview: Deletes, Close Deletes, Capping Changes

With a couple of weeks to review cutoff, there are two stocks in deletion zone and another two that are close to the deletion zone. Most likely, no...

Logo
392 Views
Share
04 Aug 2023 06:00

ASX Short Interest Weekly (Jul 28th): Woodside Energy, NAB, Macquarie, BHP, CSL, Northern Star Re

We estimate the ASX short interests to be USD 16.2bn and highlight short interest changes in Woodside Energy, NAB, Macquarie, BHP, CSL, Northern...

Logo
408 Views
Share
20 Jul 2023 16:58

ASX Short Interest Weekly (Jul 14th): Fortescue Metals, BHP, Lynas Rare Earth, Suncorp, Woolworths

We analyzed ASX short interest report for the past week and highlight short interest changes in Fortescue Metals, BHP, Lynas Rare Earth, Suncorp,...

Logo
563 Views
Share
14 Jul 2023 11:52

ASX Short Interest Weekly (Jul 7th): Lynas Rare Earth, Northern Star Re, Iluka Resources, Worley

We analyzed ASX short interest report for the past week and highlight short interest changes in Lynas Rare Earth, Northern Star Re, Iluka...

Logo
471 Views
Share
07 Jul 2023 06:00

ASX Short Interest Weekly (Jun 30th): Rea, ANZ, Xero, Westpac, NAB, Liontown

We analyzed ASX short interest report for the past week and highlight short interest changes in Rea, ANZ, Xero, Westpac, Natl Aust Bank, Liontown.

Logo
526 Views
Share
x